Bergen, Norway, 30 January 2020 - A Extraordinary General Meeting in BerGenBio
ASA will be held on 20 February 2020 at 17:00 hours (CET) at the company's
offices in Møllendalsbakken 9, 5009 Bergen.
The notice, registration form and power of attorney are attached to this
release. The notice will be sent to all registered shareholders and is available
at https://www.bergenbio.com/investors/general- meetings/
-End-
For further information, please contact:
Richard Godfrey CEO, BerGenBio ASA
richard.godfrey@bergenbio.com
+47 917 86 304
Rune Skeie CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.